Reliability of digital PCR in detecting KRAS mutation in colorectal cancer using plasma sample: A systematic review and meta-analysis

BACKGROUND: Test on the KRAS somatic mutation status is necessary before cetuximab and panitumumab treatments are given to colorectal cancer patients. Metastatic colorectal cancer patients sometimes lack tumor tissue samples, and the testing of KRAS mutation in plasma samples requires highly sensiti...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Peng, Cai, Peiling, Xie, Jing, Zhang, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360253/
https://www.ncbi.nlm.nih.gov/pubmed/32664155
http://dx.doi.org/10.1097/MD.0000000000021171

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360253/
https://www.ncbi.nlm.nih.gov/pubmed/32664155
http://dx.doi.org/10.1097/MD.0000000000021171

Ejemplares similares